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ABSTRACT: 
During the past 20 years Australian federal and state governments have funded many initiatives to bolster 
organ donation. Despite large investments of time, effort and money, Australia’s deceased donation rate is 
amongst the world’s lowest and has only slightly increased from 11.9 donors per million people (pmp) in 
1990 to 13·8 donors pmp in 2010. An often-cited explanation for this situation is that Australia’s success in 
increasing levels of public health and safety has reduced the number of potential deceased organ donors. 
We refer to this as the “Failure Because of Success” hypothesis. Although commonly accepted, this 
hypothesis is largely untested.  Analysis of health data on road trauma and stroke deaths from Australia 
and other OECD countries reveals that improvements in public health and safety do not provide an 
adequate explanation for Australia’s low organ donor rates. 
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FIGURE 11: Deceased Organ Donation Rates for 2009 
 
INTRODUCTION: 
Organ transplantation is a well-established treatment for many chronic diseases, with the potential to save 
lives and significantly improve the quality of life of severely ill people. Unfortunately, the demand for 
organs exceeds supply and despite Australia’s excellent record in organ transplantation outcomes, (1,2) and 
Australian federal and state governments’ continued investment of substantial resources to improve 
donation rates, (3) Australia’s deceased organ donation rate continues to languish in the bottom third of 
OECD donor rankings (Figure 1). While much discussion has centred on recent improvements to Australia’s 
organ donation rates, Australia’s 2010 deceased donor rate of 13·8 donors pmp is less than one half of 
(world leading) Spain’s 2010 rate of 32 donors pmp (4) (in 1989 both Australia and Spain had virtually 
identical deceased donor rates). Australia’s low donation rate is frequently explained by reference to 
success in increasing levels of public health and safety, which have directly reduced the number of 
potential organ donors. (5–8) 
 
With the exception of a relatively small but increasing number of patients who donate organs after cardiac 
death, virtually all solid organs for transplant in Australia are retrieved from brain dead donors. (9) In 
Australia, the types of donor death are tracked and categorised into six broad categories (each with its own 
subcategories) which largely parallel the types of donor deaths tracked in many other OECD countries. 
These are: Strokes (Cerebral Vascular Accidents (CVA)), Road Trauma (RT), Non-Road Trauma, Cerebral 
Tumour, Hypo/Hyper Anoxia and Other (Unspecified). (9–17) Of these, the majority of deceased donors are 
the victims of CVA and RT. (The percentage of these deaths is broadly similar across most OECD countries 
(Figures 2a, 2b & 2c).) 
 
Figure 2a - Percentage of Donor Death Caused by Road Trauma Fatalities by Country (9–17) 
 
Figure 2b - Percentage of Donor Death Caused by CVA Fatalities by Country (9–17) 
 
Figure 2c - Percentage of Donor Death Caused by Road Trauma & CVA Fatalities (combined) by Country (9–17) 
 
Over the past several decades, Australian road trauma (RT) fatalities have steadily fallen from 13·66 deaths 
per 100,000 population in 1990 to 6·8 in 2009 (18) (Figure 3). Rates of death from CVA in Australia have 
similarly declined from 61·2 per 100,000 population in 1990 to 35·2 in 2006 (19) (Figure 4). The fact that 
these significant reductions in death rates from RT and CVA have occurred parallel to a long period of stasis 
in Australian deceased organ donation rates has supported lay and professional claims that Australia’s 
failure to improve organ donation rates is due to success in saving people’s lives through improvements in 
public health and safety, thereby depleting our pool of potential organ donors. (5–8) We refer to this 
notion as the “Failure Because of Success” hypothesis. 
 
The validity of this assumption has generally been accepted as self-evident and true despite the fact that 
the quantum of the impact of road trauma and CVA deaths on overall organ donation rates has not been 
fully examined. In this paper we examine this argument by comparing the RT death, CVA death and 
deceased donation rates for seven leading donor countries with those from Australia. 
 
METHOD: 
Using published reports (9–11,13,14) and data from the International Registry of Donation and Transplants 
(IRODAT) complemented with unpublished data from several other sources (12,15–17), we analysed the 
annual deceased organ donation rates for 54 countries from 1990 through to 2009. We then extracted data 
for the seven leading donor countries, which were Spain, Portugal, France, USA, Belgium, Italy and Austria. 
For the purposes of this study, we define the term “leading donor countries” as those countries whose 
deceased donor rates exceeded 20 donors pmp for at least five of the ten years between 2000 and 2009. 
These countries’ deceased donation rates were then compared to that of Australia for the same time 
                                                          
1 All tables and figures are located at the end of this article. 
period. (Puerto Rico, which showed the greatest improvement in deceased donation rates of all the 
countries during the time period analysed is not included because we were unable to find reliable data on 
CVA and RT fatality rates for the period under study). 
 
Road Trauma (RT) fatality rates from the International Road Traffic and Accident Database (IRTAD) for the 
leading donor countries and for Australia were then compared for the same time period (1990 through 
2009). A Road Trauma fatality was defined as death where road trauma was the primary cause of the 
death, occurring within 30 days of a traffic accident. 
 
Stroke (CVA) death data from the Organisation of Economic Co-operation and Development (OECD) Health 
Statistics Database for the leading donor countries and Australia was also compared for the same time 
period.  CVA deaths were defined as a death whose cause was listed as ICD I60 through I69. 
 
 
FINDINGS: 
FIGURE 3: Road Trauma Fatality rates by country from 1990 to 2009 
 
Road Trauma Mortality 
Figure 3 shows that all eight countries had significant reductions in road trauma fatality rates from 1990 to 
2009. During the past 20 years, the trend for RT fatality rates for the majority of the countries studied have 
essentially merged. Spain, at 5·9 fatalities per 100,000 population is the lowest, with both Australia and 
France next at 6·8, followed closely by Italy, Austria and Portugal at 7·1, 7·6 and 7·9, respectively (Table 1). 
Australian RT fatality rates improved significantly during the past 20 years, and although it started from a 
lower (safer) base, its improvement lags significantly behind that of many other leading donor countries. 
Australia ranks sixth in terms of rate percentage reduction in RT mortality (50% reduction). The USA shows 
the smallest net reduction of RT fatality rates, dropping from 17·88 per 100,000 population in 1990 to 
12·25 in 2008 (31% reduction). Spain and Portugal show the greatest improvement with each having 
reduced its RT fatality rate by more than 70%. Spain, Portugal and France’s performance in increasing road 
safety is particularly noteworthy given the dramatic increases in deceased donation rates that occurred in 
these countries during the same time period (see Figure 5).  
 
FIGURE 4: CVA Fatality rates by country from 1990 to 2008 
 
CVA Mortality 
All eight countries examined have achieved steep reductions in CVA fatality rates during the time period 
studied (see Figure 4). While the incomplete data sets in the OECD database records make analysis of CVA 
fatality rates beyond the 2006 time period difficult, certain trends are evident. Portugal shows a 
surprisingly high CVA death rate--several times that of other countries (i.e. in 1990, Portugal’s CVA 
mortality rate was 204·7 per 100,000 population while that of Spain was 86·2, Australia’s was 68·2 and the 
USA was 47·4) (Table 2). Of the eight countries included in the analysis, as of 2004 (the latest year most 
countries reported), at 40·2 CVA deaths, per 100,000 population, Australia ranks in the middle in CVA 
fatality rates with 40·2 CVA deaths per 100,000 population per year, while France, the USA and Austria 
show the lowest CVA fatality rates with 30·6, 35·7 and 40·1 respectively. Therefore, as is the case with RT 
fatalities, reductions in CVA fatalities do not appear to have compromised the leading donor countries’ 
ability to maintain, and in most cases, dramatically improve their organ donor rates. 
 
FIGURE 5: Deceased organ donation rates by country from 1990 to 2009 (9–17,20) 
 
Deceased Organ Donation Rates 
All countries, with the exception of Australia and Austria, demonstrated significant increases in their 
deceased organ donation rates during the study period (see Figure 5). Italy showed the highest percentage 
rate improvement at more than 238% from 1993 to 2009. Spain, Portugal, France and the USA also showed 
dramatic increases to their deceased donation rates (Spain, from 17·8 in 1990 to 34·0 in 2009; Portugal 
from 15·0 in 1993 to 31·0 in 2009; France from 17·1 in 1993 to 24·2 in 2009 and USA from 17·9 in 1992 to 
24·0 in 2009) (Table 3). Overwhelmingly, these countries demonstrated steady, progressive improvement in 
rates of deceased organ donation throughout the study period. 
 
With the exception of the 13·2% decrease observed in Austrian donations during the study period, the 
sustained and significant increases in donation rates in all other leading donor countries are independent of 
the steady and notable improvements (reductions) observed in their road trauma and stroke fatality levels. 
 
DISCUSSION: 
Whether measured in relative or absolute terms, Australia’s performance in increasing levels of public 
health and safety and achieving significant reductions in road trauma and CVA deaths is neither unique nor 
exemplary when compared to the improvements seen in many of the leading donor countries analysed in 
this study. Importantly, most of the world’s highest performing donor countries have succeeded in 
improving public safety and reducing mortality from cerebrovascular disease while concurrently increasing 
their deceased organ donor rates. With one exception (Austria), their achievements demonstrate that 
success in improving public health and reducing both road trauma and CVA deaths does not necessarily 
compromise success in substantially raising deceased organ donation rates. Success in improving public 
safety through reducing road trauma and CVA deaths does not, therefore, appear to adequately explain 
failure to achieve improvements in organ donation rates.  (It is theoretically possible, of course, that 
management of CVA and Road Trauma in Australia differs from other leading donor countries and that 
neurological outcomes, including a diagnosis of brain death, in such circumstances, are also different.  
There is however, no data to suggest that this is true, and even if it were, the impact on donation rates 
would be minimal at best.) 
 
This raises a series of troubling questions. The first is, how could a “failure because of success” hypothesis 
such as we have described have gained such political, medical and lay traction and been so widely adopted 
as factually correct without being subjected to rigorous examination? The second is whether there is, or 
has been, a “cost” to our donor rates through uncritical acceptance both of this hypothesis and the idea 
that Australia is somehow “different” to other western democracies in terms of improvements made to 
public health and safety.  
 
While Australia’s achievements in improving levels of public health and safety are laudable, and, as some 
evidence in both Spain and the UK demonstrates, might have shrunk the potential donor pool by reducing 
the over-all number of Australians who would potentially become brain dead (4,21,22), very recent 
evidence from Spain shows that this shrinkage in the potential donor pool can be more than compensated 
for through implementation of hospital-wide donor best practice recommendations and through the 
development of a systemic approaches to organ donation that include, but are not limited to the 
identification and management of donors in hospitals (23).  The fact that many leading donor countries 
have been successful at improving deceased donation rates while at the same time achieving impressive 
improvements in public health and safety, suggests that improvements in public health and safety are not a 
sufficient explanation for Australia’s low organ donor rates. Indeed, the success of these countries in 
achieving both improvement in public health and safety and high deceased organ donation rates suggests 
that they have been able to “do more with less.” 
 
We believe that continued acceptance of this failure because of success hypothesis prevents Australia from 
acknowledging that success in increasing public health and safety is not incompatible with success in 
achieving high organ donation rates. We hope that by demonstrating that simultaneous improvements to 
both public safety and organ donation is not only possible, but common amongst the world’s leading donor 
countries, we can shift Australia’s attention onto evidence-based explanations for why Australia continues 
to have such a low supply of organs for transplantation and away from this convenient mythology. 
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Tables & Figures 
 
TABLE 1: ROAD TRAUMA FATALITIES BY COUNTRY 1990–2009 (18) 
(Deaths per 100,000 Population) 
 Australia Spain Portugal France USA Belgium Austria Italy 
1990 13·66 23·2 28·25 19·82 17·88 19·86 20·26 12·4 
1991 12·23 22·73 30·16 18·54 16·44 18·75 20·0 14·0 
1992 11·28 20·06 28·86 17·3 15·39 16·68 17·89 14·15 
1993 11·05 16·33 25·21 16·63 15·58 16·49 16·23 12·6 
1994 10·8 14·35 23·32 15·6 15·64 16·75 16·86 12·43 
1995 11·16 14·67 25·23 15·32 15·9 14·3 15·22 12·28 
1996 10·76 13·97 25·38 14·66 15·86 13·37 12·9 11·67 
1997 9·54 14·26 23·38 14·44 15·69 13·4 13·87 11·7 
1998 9·38 15·12 22·44 15·19 15·36 14·72 12·07 11·89 
1999 9·32 14·52 21·02 14·39 15·3 13·68 13·5 11·6 
2000 9·49 14·54 18·13 13·64 15·25 14·36 12·18 12·2 
2001 8·95 13·75 16·18 13·82 14·79 14·48 11·93 12·27 
2002 8·73 12·87 16·09 12·9 14·93 13·12 11·83 12·25 
2003 8·15 12·8 14·76 10·16 14·75 11·71 11·47 11·45 
2004 7·86 11·02 12·29 9·34 14·63 11·18 10·74 10·58 
2005 7·98 10·22 11·8 8·78 14·72 10·43 9·33 9·95 
2006 7·74 9·33 9·58 7·7 14·3 10·17 8·8 9·65 
2007 7·63 8·64 9·6 7·5 13·7 10·0 8·3 8·68 
2008 6·75 6·85 8·3 6·91 12·25 8·9 8·15 7·94 
2009 6·8 5·9 7·9 6·8 11·1 8·9** 7·6 7·1 
         
% Reduction 
from 1990 
to 2009 
Level 
50·22 74·57 72·04 65·69 37·92 55·19 62·49 42·83 
 
**At time of publication, Belgium had not reported its 2009 RT fatality rate to the IRTAD.  This number 
represents its 2008 rate. 
  
 
TABLE 2: CVA FATALITIES BY COUNTRY 1990–2008 (19) 
(ICD Codes I60-I69, Deaths per 100,000 Population, Age standardised) 
 Australia Spain Portugal France USA Belgium Austria Italy 
1990 68·20 86·20 204·70 52·90 47·40 68·80 95·30 88·60 
1991 64·70 85·60 202·50 52·00 45·70 66·20 94·20 87·60 
1992 63·00 78·60 188·50 48·70 44·70 64·60 88·00 84·70 
1993 61·10 75·20 190·80 47·30 45·40 65·90 82·80 83·50 
1994 63·10 71·90 172·30 43·70 45·30 61·50 80·30 80·60 
1995 59·20 68·10 170·50 43·10 45·70 58·60 77·40 73·40 
1996 57·60 64·40 166·80 42·40 45·20 58·50 80·10 68·60 
1997 52·50 60·90 151·00 40·90 44·30 57·40 77·00 68·10 
1998 51·60 59·70 146·00 40·50 42·80 51·4 73·20 68·20 
1999 49·30 58·70 140·80 39·40 44·00 49·8 69·90 63·90 
2000 47·40 53·00 132·50 37·00 43·20  65·70 61·30 
2001 44·90 51·60 124·90 35·90 41·10  59·50 57·10 
2002 43·90 49·20 116·80 34·60 39·90  58·20 55·40 
2003 41·70 49·10 111·20 34·50 38·00  52·60 56·70 
2004 40·2 44·00  30·60 35·70 43·9 40·10  
2005  43·30  29·90 33·40  38·30  
2006 35·2   27·8   37·3 45·8 
2007    26·0   34·8 44·2 
2008       33·5  
2009         
         
% Reduction 
from 1990 
to last year 
reported 
48·39 49·77 45·68 50·85 29·54 36·19 64·85 50·11 
  
TABLE 3: DECEASED DONOR RATES BETWEEN 1990-2009 (9–17,20) 
(Deceased Donation per 1,000,000 Population) 
 Australia Spain Portugal France USA Belgium Austria Italy 
1990 11·9 17·8     28·8  
1991 12·1 20·2     26·5  
1992 12·3 21·7   17·9  22·1  
1993 12·3 22·6 15·0 17·1 19·2 21·7 25·8 6·3 
1994 10·2 25·0 18·4 15·3 20·2 22·8 21·3 7·9 
1995 10·2 27·0 20·0 15·0 21·0 19·0 22·9 9·8 
1996 10·6 26·8 21·2 15·1 21·2 20·9 24·7 10·9 
1997 10·2 29·1 20·6 14·9 21·2 22·5 19·5 11·6 
1998 10·4 31·5 16·6 16·8 22·4 19·4 20·7 12·3 
1999 8·6 33·6 19·0 16·2 22·5 23·8 24·8 13·6 
2000 10·2 33·9 19·4 16·9 23·0 25·6 23·2 15·2 
2001 9·5 32·4 20·2 17·8 20·7 21·5 23·6 17·0 
2002 10·4 33·6 21·7 20·3 20·8 21·6 22·1 18·1 
2003 9·0 33·7 19·0 18·6 21·3 23·3 22·0 18·5 
2004 10·8 34·6 22·1 21·0 23·1 21·1 22·0 21·1 
2005 10·0 35·0 19·0 22·2 23·8 22·8 24·5 21·0 
2006 9·8 33·8 20·1 23·2 25·0 26·4 24·3 21·7 
2007 9·4 34·3 23·9 25·3 26·6 28·0 21·9 20·9 
2008 12·1 34·2 26·7 25·3 26·0 24·8 20·1 21·0 
2009 11·3 34·0 31·0 24·2 24·0 25·8 25·0 21·3 
         
% Increase 
from first 
reported 
donation 
rate 
-5·0 91·0 108·7 41·5 34·0 18·9 -13·1 238·1 
  
FIGURE 1: Deceased Organ Donation Rates for 2009 (20) 
 
Note:  At the time of publication, Cyprus, Luxembourg and the Slovak Republic did not yet report 2009 rates to the IRODaT.  2008 rates were used. 
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Figure 2a - Percentage of Donor Death Caused by Road Trauma Fatalities (9–17) 
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Figure 2b - Percentage of Donor Death Caused by CVA Fatalities (9–17) 
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Figure 2c - Percentage of Donor Death Caused by Road Trauma & CVA Fatalities (combined) (9–17) 
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FIGURE 3: Road Trauma Fatality rates by country from 1990 to 2009 (18) 
(RT Fatality defined as death within 30 days, with RT the primary cause) 
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FIGURE 4: CVA Fatality rates (ICD I60 – I69) from 1990 to 2008 (19) 
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FIGURE 5: Deceased organ donation rates from 1990 to 2009 (20) 
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